Internal Funding Opportunities
Research Seed Grant (RSG) cycle (winter-spring)
The goal of the RSG program is to assist faculty in generating preliminary data that can be used to support applications for extramural funding.
RSG applications will typically be solicited in January. These applications will be evaluated for scientific merit by the Grant Review Committee (GRC).
Because RSG funding is intended to develop grant-writing skills, and hence the competitiveness of faculty who are not highly experienced at writing grant proposals, new and clinical investigators can submit their applications in advance of the regular application date and receive a critique that can be used to refine and improve the final application.
Four RSG will be awarded in amounts not to exceed $15,000 each, assuming that adequate numbers of meritorious applications are submitted. The funding period will be from July 1 through June 30, with no extensions permitted. One of the four grants will be designated as the Clinician-Scientist Award. Meritorious applications that propose research related to diabetes, Alzheimer’s disease, or heart disease may be funded through the IHIA endowment or the Eskridge gift (see below).
Faculty who receive RSG funding are required to submit a post-award report to the ADRFA within 2 months after the end of the period of funding in order to maintain eligibility for future RSG funding.
Clinician Scientist Award (CSA)
The goal of the CSA is to support the development of clinician-scientists at SIUSM. For purposes of this award, a clinician-scientist is defined as a faculty member who holds an MD/DO degree and who maintains a clinical practice. Assuming that meritorious applications are submitted, one grant in an amount not to exceed $15,000 will be awarded annually in conjunction with the RSG program. Requirements for RSG applications will apply. However, in the abstract and specific aims, the applicant for a CSA should include an explanation of how the applicant qualifies as clinician-scientist under the above definition.
Illinois Health Improvement Association (IHIA) Award
The goal of the IHIA endowment is to support research in the areas of diabetes and Alzheimer’s disease. Assuming that meritorious applications are submitted, one grant will be awarded annually as one of the designated RSG awards. Requirements for the RSG program will apply.
Bernie L. Eskridge Heart Disease Research Award
The goal of the Eskridge gift is to support research in the area of heart disease. Assuming that meritorious applications are submitted, one grant will be awarded annually as one of the RSG awards. Requirements for the RSG program will apply.
1. Near-Miss (N-M) program The goal of the Near-Miss funding program is to support the improvement of grant applications that were submitted to external agencies but were not funded. Eligible parent grants must meet three criteria: 1) generate full F&A (IDC) return (currently 45.5%), 2) have an associated critique, and 3) be eligible for resubmission to the parent agency. NM applications are reviewed by an ad hoc review committee appointed by the ADRFA.
NM funding will be awarded in amounts not to exceed $15,000, with applications following the guidelines provided below. The goal will be to fund 2 grants annually, with a funding period from January 1 through June 30, assuming adequate numbers of meritorious applications are submitted. Extensions of the funding period are not permitted.
Faculty who receive funding through the NM mechanism are required to submit 1) a post-award report to the ADRFA within 2 months after the end of the period of funding and 2) a revised application to the parent external funding agency. Faculty who do not comply with these requirements will not be eligible for future Near-Miss funding.
2. Developmental grants The following 3 application types will be solicited in the fall. Standard requirements for the RSG funding cycle will apply. These applications will be evaluated for scientific merit by the GRC. Funding will be made in amounts not to exceed $25,000. The funding period will be January 1 through December 31. Extensions of the funding period are not permitted.
a. Discovery Science Grant (DSG)
The goal of the DSG is to facilitate the generation and/or analysis of large data sets for purposes of hypothesis generation. This initiative is based on the recognition that NIH study sections often view so-called discovery science as ‘fishing,” whereas in fact many unique discoveries and testable hypothesis can arise from this approach. Because SIUSM does not have a core facility for generating these types of data, SIUSM faculty may be unable to perform these important and potentially paradigm-changing studies. The DSG will allow faculty to submit applications to generate and analyze large data sets (e.g., by procuring samples for and conducting genotyping, microarray analysis, etc.) or to interrogate existing data bases.
Assuming that meritorious applications are submitted, one grant will be awarded annually in an amount not to exceed $25,000. Standard requirements for the RSG funding cycle will apply. The proposal should clearly explain the research question and how the proposed assessment may lead to novel hypothesis suitable for development of an NIH grant. Attention should be given to sound experimental design and data analysis, including statistical assessments. Collaborations between faculty to generate and use a given data set are encouraged.
Faculty who receive funding through the DSG mechanism will be required to deposit the data on the ADRFA web site where it will be made accessible to all faculty members. Recipients must submit a post-award report to the ADRFA within 2 months after the end of the period of funding. Faculty will be eligible to apply for additional DSG funds only after an NIH application has been submitted based on the initial award.
b. Team Development Grant (TDG) for Patient-Oriented Research
The goal of the TDG program is to promote the development of new research collaborations with potential translational impact. Assuming that meritorious applications are submitted, one grant will be awarded annually in the amount of $25,000. Standard requirements for the RSG funding cycle will apply. However, in the abstract and specific aims, the applicant for a TDG should include an explanation of how the proposal will contribute to formation of a new research team and have potential translational impact. Collaborations of clinical and basic science personnel and team members from different departments are particularly encouraged. All members of the team should have well-defined roles on the project. To qualify as a new team, faculty may not have previously published together as co-authors.
c. Patient-Oriented Research Grant (PORG)
The goal of the PORG program is to promote research projects and collaborations that support any level of the translational research continuum from bench research through clinical research and into application of findings into the community. To be eligible for this funding mechanism, proposals must make use of human subjects, samples, data, or environments. Assuming that meritorious applications are submitted, one grant will be awarded annually in the amount of $25,000. In the abstract and specific aims of the proposal, the applicant for a PORG should include an explanation of how the proposal qualifies for the program according to the above definition. Otherwise, standard requirements for the RSG funding cycle will apply.
Concept Development Award (CDA)
The goal of the CDA program is to help in the advancement of inventions by providing development costs that are not met by other means. Two award cycles will occur each year, with up to $15,000/award. Inventions can receive multiple awards. The CDA program is managed by the Office of Technology Transfer and the Patent & Copyright Committee.
Frank J. Toth Research Award
This award will be made annually to a non-faculty SIUSM employee who works in support of the research mission of the School. The award recipient will be determined based on nominations and letters of support. Eligibility for this award should be widely construed to include any non-faculty employee whose work furthers the research effort. The award consists of a plaque and a travel allocation to allow the recipient to attend a meeting that will further the awardee’s education, training, and/or career development to the benefit of the School, as approved by the supervisor. Solicitation and review of nominations will be conducted annually in the winter-spring by the Research Policy Committee, which will recommend a recipient to the Dean.